“SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain

Title: “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain

Volume: 4 Issue: 4

Author(s): Kenneth Maiese, Zhao Zhong Chong and Yan Chen Shang

Affiliation:

Keywords: Amyotrophic lateral sclerosis, diabetes, apoptosis, FOXO3a, FKHRL1, Akt, erythropoietin, neuromuscular disease, oxidative stress, psychiatric

Abstract: The Forkhead transcription factor FOXO3a has emerged as a versatile target for diseases that impact upon neuronal survival, vascular integrity, immune function, and cellular metabolism. Enthusiasm is high to fill a critical treatment void through FOXO3a signaling for several neurodegenerative disorders that include aging, neuromuscular disease, systemic lupus erythematosus, stroke, and diabetic complications. Here we discuss the influence of FOXO3a upon cell survival and longevity, the intricate signal transduction pathways of FOXO3a, insights into present disease models, and the potential clinical translation of FOXO3a signaling into novel therapeutic strategies.

Cite this article as:

Maiese Kenneth, Chong Zhong Zhao and Shang Chen Yan, “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain, Current Neurovascular Research 2007; 4 (4) . https://dx.doi.org/10.2174/156720207782446306